Discuss This Drug

montelukast

CHEBI:CHEBI_50730

Chemical Information

Molecular Formula
C35H36ClNO3S
Molecular Mass
586.18398
Charge
0
SMILES
CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC1)CC(O)=O)c1cccc(\C=C\c2ccc3ccc(Cl)cc3n2)c1
InChI
InChI=1S/C35H36ClNO3S/c1-34(2,40)30-9-4-3-7-25(30)13-17-32(41-23-35(18-19-35)22-33(38)39)27-8-5-6-24(20-27)10-15-29-16-12-26-11-14-28(36)21-31(26)37-29/h3-12,14-16,20-21,32,40H,13,17-19,22-23H2,1-2H3,(H,38,39)/b15-10+/t32-/m1/s1
InChIKey
UCHDWCPVSPXUMX-TZIWLTJVSA-N

Alternative Names

  • (R-(E))-1-(((1-(3-(2-(7-Chloro-2-quinolinyl)ethenyl)phenyl)-3-(2-(1-hydroxy-1-methylethyl)phenyl)propyl)thio)methyl)cyclopropaneacetic acid
  • {1-[({(1R)-1-{3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl}-3-[2-(2-hydroxypropan-2-yl)phenyl]propyl}sulfanyl)methyl]cyclopropyl}acetic acid
  • 1-[[[(1 R)-1-[3-[(1E)-2-(7-chloro-2-quinolinyl)ethenyl] phenyl]-3-[2-(1-hydroxy-1-methylethyl)phenyl]propyl]sulfanyl]methyl]cyclopropaneacetic acid
  • montelukast
  • Montelukast
  • MONTELUKAST

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

DRON_00010000
88249
oboInOwl#hasDbXref
Wikipedia:Montelukast
core#notation
CHEBI:50730

Additional References

Wikipedia:Montelukast

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
dosage_form
GRANULE
application_number
ANDA205107
product_ndc
31722-726
route
ORAL
package_ndc
60312-0711-0
spl_id
f200a4c8-a6d4-86e0-e053-2a95a90a5a4e
oboInOwl#hasOBONamespace
chebi_ontology
DRON_00010000
88249
oboInOwl#hasDbXref
Wikipedia:Montelukast
oboInOwl#hasAlternativeId
CHEBI:6992
oboInOwl#id
CHEBI:50730
generic_name
Montelukast Sodium Process 1
brand_name
Montelukast sodium
brand_name_base
Montelukast sodium
RO_0000087
http://purl.obolibrary.org/obo/CHEBI_49159
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#3_STAR
BFO_0000053
http://purl.obolibrary.org/obo/DRON_00000063
chebi#is_conjugate_acid_of
http://purl.obolibrary.org/obo/CHEBI_49165
package_description
1 BAG in 1 DRUM (60312-0711-0) / 125000 TABLET, CHEWABLE in 1 BAG
has_treatment
http://purl.obolibrary.org/obo/DOID_0080816
rdf-schema#domain
https://w3id.org/def/predibionto#has_side_effect26411
chebi#is_conjugate_base_of
http://purl.obolibrary.org/obo/CHEBI_49165
owl#someValuesFrom
t3010484
owl#annotatedSource
t238798
labeler_name
Slate Run Pharmaceuticals, LLC.
marketing_start_date
20061214
listing_expiration_date
20241231
rxcui
404406
unii
MHM278SD3E
spl_set_id
4e5aa7a6-ffd0-4cc9-89b5-04640bb5cfdd
manufacturer_name
Direct_Rx
package_marketing_start_date
14-DEC-06
core#notation
CHEBI:50730
active_ingredient_name
MONTELUKAST SODIUM
active_ingredient_strength
4 mg/.0005kg
pharm_class_epc
Leukotriene Receptor Antagonist [EPC]
pharm_class
Leukotriene Receptor Antagonists [MoA]
pharm_class_moa
Leukotriene Receptor Antagonists [MoA]
upc
0369844076016
nui
N0000000083
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class